NCT03033264View on ClinicalTrials.gov

Labor Induction With Dinoprostone in Oppose to Cervical Ripening Balloon as a Factor of BMI.

NACompletedINTERVENTIONAL
Enrollment

164

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

July 31, 2020

Study Completion Date

October 1, 2020

Conditions
Induction of Labor
Interventions
DRUG

Dinoprostone

10 mg of a Dinoprostone vaginal insert.

DEVICE

Double lumen cervical ripening balloon.

Double lumen cervical ripening balloon.

Trial Locations (1)

Unknown

Rambam health care campus, Haifa

All Listed Sponsors
lead

Rambam Health Care Campus

OTHER

NCT03033264 - Labor Induction With Dinoprostone in Oppose to Cervical Ripening Balloon as a Factor of BMI. | Biotech Hunter | Biotech Hunter